BEHRS MELISSA KELLY Insider Trading Activity

Also formerly known as KELLY MELISSA
Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$2.72M

Insider Activity of BEHRS MELISSA KELLY

Biography of BEHRS MELISSA KELLY

No biography is available at this moment.

2019-04-09SaleGeron Corporation
GERN
EVP, Chief Business Officer
241,270
0.1421%
$2.00$482,540-23.08%
2015-05-29SaleGeron Corporation
GERN
EVP BD and Port&Alliance Mgmt
4,760
0.003%
$3.84$18,278-14.77%
2014-05-29SaleGeron Corporation
GERN
EVP Portfolio & Alliance Mgmt
9,652
0.0061%
$2.10$20,269+51%
2014-04-01SaleGeron Corporation
GERN
EVP Portfolio & Alliance Mgmt
24,620
0.0158%
$2.13$52,441+26.75%
2013-01-17SaleGeron Corporation
GERN
SVP Alliance and Prog Mgmt
56,584
0.0438%
$1.65$93,137-9.55%
2012-05-30SaleGeron Corporation
GERN
SVP Strategic Portfolio Mgmt
37,820
0.0309%
$1.37$51,813+8.8%
2011-06-14SaleGeron Corporation
GERN
SVP Strategic Portfolio Mgmt
50,524
0.0429%
$4.28$216,243-50.91%
2011-05-24SaleGeron Corporation
GERN
SVP Strategic Portfolio Mgmt
5,950
0.0048%
$4.47$26,597-53.48%
2010-06-02SaleGeron Corporation
GERN
SVP Oncology
21,234
0.0211%
$5.43$115,301-10.3%
2010-05-24SaleGeron Corporation
GERN
SVP Oncology
4,672
0.0049%
$5.11$23,874+1.27%
2009-05-29SaleGeron Corporation
GERN
SVP Oncology
4,554
0.005%
$6.35$28,918-6.01%
2009-05-26SaleGeron Corporation
GERN
SVP Oncology
13,638
0.0155%
$6.75$92,057-8.36%
2009-02-02SaleGeron Corporation
GERN
SVP Oncology
29,530
0.0368%
$8.12$239,784-18.1%
2009-01-05SaleGeron Corporation
GERN
SVP Oncology
17,722
0.0206%
$4.90$86,838+27.7%
2008-11-05SaleGeron Corporation
GERN
SVP Oncology
47,690
0.0632%
$4.05$193,145+63.24%
2008-01-04SaleGeron Corporation
GERN
SVP Oncology
17,822
0.0237%
$5.34$95,169-17.54%
2006-01-09SaleGeron Corporation
GERN
VP, Oncology
8,441
0.013%
$8.56$72,255-11.98%
2005-07-29SaleGeron Corporation
GERN
VP, Oncology
65,571
0.1139%
$10.88$713,412-22.13%
2005-01-13SaleGeron Corporation
GERN
VP, Oncology
8,648
0.0162%
$8.57$74,113+2.39%
2004-04-06SaleGeron Corporation
GERN
VP, Oncology
2,029
0.0047%
$9.60$19,478-23.34%
Total: 20
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.